Repurposing of artesunate, an antimalarial drug, as a potential inhibitor of hepatitis E virus
Repurposing of artesunate, an antimalarial drug, as a potential inhibitor of hepatitis E virus
About this item
Full title
Author / Creator
Publisher
Vienna: Springer Vienna
Journal title
Language
English
Formats
Publication information
Publisher
Vienna: Springer Vienna
Subjects
More information
Scope and Contents
Contents
Hepatitis E virus (HEV) is endemic in several developing countries of Africa and Asia. It mainly causes self-limiting waterborne infections, in either sporadic or outbreak form. Recently, HEV was shown to cause chronic infections in immunosuppressed individuals. Ribavirin and interferon, the current off-label treatment options for hepatitis E, have...
Alternative Titles
Full title
Repurposing of artesunate, an antimalarial drug, as a potential inhibitor of hepatitis E virus
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10141844
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10141844
Other Identifiers
ISSN
0304-8608
E-ISSN
1432-8798
DOI
10.1007/s00705-023-05770-1